BIOLASE (NASDAQ:BIOL) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL) in a report published on Thursday morning. The brokerage issued a sell rating on the medical technology company’s stock.

BIOLASE Stock Up 7.0 %

BIOLASE stock opened at $0.01 on Thursday. The business has a 50 day moving average price of $0.01 and a two-hundred day moving average price of $0.02. The stock has a market cap of $253,893.20, a price-to-earnings ratio of 0.00 and a beta of 0.67. BIOLASE has a 12 month low of $0.02 and a 12 month high of $1.94.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.